Related Experiment Video
Updated: Aug 14, 2026

10:49
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 19, 2013
Controlled clinical trials in cancer research
1University of Oslo, Norway.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1996
Summary
This guide explains clinical trial design and analysis, covering protocols, bias avoidance, and statistical concepts like p-values and power. It emphasizes correct interpretation and addresses common errors in clinical research.
Area of Science:
- Clinical Research Methodology
- Biostatistics
- Medical Research Design
Background:
- Understanding clinical trial design and analysis is crucial for researchers and medical literature consumers.
- Effective research requires knowledge of protocols, bias mitigation, and statistical interpretation.
Purpose of the Study:
- To provide a comprehensive overview of essential clinical trial design and analysis principles.
- To guide researchers in avoiding bias, understanding statistical concepts, and correctly interpreting results.
Main Methods:
- Explanation of clinical trial protocol components and bias-avoidance strategies.
- Definition and explanation of p-values and common statistical analysis methods.
- Discussion of statistical power, sample size estimation formulas, and interpretation of results.
Main Results:
- Clarification of statistical power and provision of sample size estimation formulas.
- Identification of common misinterpretations and errors in clinical trial result analysis.
- Addressing complexities of multiple significance testing, including interim analyses, multiple endpoints, and subgroup analyses.
Conclusions:
- Accurate interpretation of clinical trial results is vital for advancing medical knowledge.
- Proper understanding of statistical methods and trial design enhances research integrity.
- This overview equips researchers with essential knowledge for conducting and interpreting clinical trials effectively.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...

